Mrsa Sinus Infection Symptoms
|
MRSA Sinus Infection Symptoms are more serious than other sinusitis infection symptoms. MRSA is a multidrug resistant infection referred to formally as Methicillin-resistant staphylococcus aureus. MRSA is a virulent strain of staphylococcus aureus which requires treatment by specific antibiotics and can require hospitalization. MRSA develops typically in the nose, respiratory tract, open wounds, IV catheters and urinary tract. MRSA is known to colonize within 24-48 hours after exposure and is especially problematic as it is resistant to treatment by the usual antibiotics such as pencillins and cephalosporins. MRSA is often acquired in hospital settings and convalescent homes where patients have weakened immune systems and open wounds. The initial presentation of MRSA includes are:
Glycopeptides: are the most common treatment for MRSA at this time MRSA sinus infection symptoms are treated with glycopeptides. Glycopeptides are a class of antibiotic, and like other antibiotics, is a compound or substance that slows down the growth of bacteria or kills bacteria or any microorganism that is antagonistic to the growth of other microorganisms “in high dilution.” The glycopeptides class of antibiotic is not taken orally typically and must be given IV for most infections. However, MRSA of the sinus area can be applied topically. When a glycopeptides is prescribed it is referred to as a “last resort” drug but due to the presence of an increase of MRSA cases it is now used more commonly. Glycopeptides are prescribed for life threatening infections, gram-positive bacteria, which are unresponsive to other antibiotics. MRSA Sinus infection symptoms will also result in inflammation of the sinus lining, especially the nasal sinuses. As sinus infections in the sinus area are frequently treated with antibiotics, the course of treatment with MRSA is reserved for MRSA exclusively. An antibiotic is a treatment that is prescribed with the purpose of eliminating the bacteria which are an underlying cause for sinusitis. Antibiotics that are prescribed by physicians are chosen due to the culture and type of infection. However, when MRSA is present the strongest antibiotics available are used. A glycopeptide is effective for the most virulent infections and come in oral, liquid and IV form but most frequently is available in IV form. Sinusitis is inflammation of the sinuses caused by a blockage in the sinus cavity caused by foreign debris. The blockage of bacteria, fungi or virus also triggers excess mucus production in the sinus cavities and inflammation due to the pathogens attacking the sinus cavity openings. When the sinus cavity openings are attacked this leads to a more serious sinus infection. Sinusitis develops typically as a result when there is existing inflammation from a cold or allergy. When bacteria get into the sinus cavities, they attack the swelling of the cavity lining, causing more inflammation. During a sinusitis infection, the cilia which are small hairs in the nasal passageways cannot perform their function of removing the debris that is blocked inside the sinus cavity. There are a myriad of symptoms that take place with a sinusitis infection. Common symptoms of a sinusitis infection include: cough, upper respiratory congestion, postnasal drip, nasal discharge, fever, facial pain and facial pressure. Sinusitis frequently requires medication and there are several different treatment options available. Some forms of sinusitis are viral and will not respond to an antibiotic. Chronic sinusitis frequently is viral in nature, however, due to secondary infections that develop from the sinusitis infection will result in the treating physician prescribing an antibiotic, at least prophylatically. The goal of treatment is to reduce the inflammation as well as prevent flare ups while draining the sinus passages. Many physicians prescribe an oral antibiotic to treat sinusitis yet with MRSA an oral antibiotic would be inappropriate as an oral antibiotic is marginally effective relying on the blood stream and blood vessels exclusively to carry medication to the infected sinus cavity. Glycopeptides are not easily absorbed into the blood stream easily, resulting in poor bioavailability. Relying on the sinus cavities to provide the medication through the limited supply of blood vessels is problematic as the blood vessels cannot deliver an effective dose of medication to the actual site of infection. The sinus cavities scant supply of blood vessels which are swollen and infected providing all the treatment to the infection results in an ineffective method for treating this area of the body, especially with the presence of MRSA which is typically treated with IV antibiotics. Therefore, a sinusitis antibiotic treatment that is not oral would be more effective in the presence of MRSA cultured as the pathogen that has caused the sinusitis infection. Sinus Dynamics offers custom compounded topical antibiotics, anti-fungals, and anti-inflammatories that are delivered topically into the sinus cavities with a state of the art nebulizer offering the glycopeptides class as topical treatment. Sinus Dynamic's nebulizer emits a fine medicated mist with 1.0 to 3.2 micron sized particle that can easily travel up into the inflamed sinus cavities and make contact with the trapped bacteria as well as reaching the inflammation at the opening of the sinus cavities. Sinus Dynamics offers the most effective treatment for all types of sinusitis infections by delivering medication directly into the sinus cavity. A topical treatment also ensures little to no side effect as well as a low systemic absorption rate. Sinus Dynamics sinus therapy is highly effective, easy to use, and safe with a 98% success rate in the treatment of patients who are suffering with sinusitis infections. Call Sinus Dynamics (877) 447-4276 to treat your MRSA Sinus Infection Symptoms to see how a topical antibiotic can treat your sinusitis infection today! Related Articles |
Categories
RSS Links |
